These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 15833092

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Topiramate in migraine prevention.
    Silberstein SD.
    Headache; 2005 Apr; 45 Suppl 1():S57-65. PubMed ID: 15833091
    [Abstract] [Full Text] [Related]

  • 3. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Apr; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 6. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 7. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 8. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group.
    JAMA; 2004 Feb 25; 291(8):965-73. PubMed ID: 14982912
    [Abstract] [Full Text] [Related]

  • 9. Topiramate for migraine prevention.
    Wenzel RG, Schwarz K, Padiyara RS.
    Pharmacotherapy; 2006 Mar 25; 26(3):375-87. PubMed ID: 16503717
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
    Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J.
    Headache; 2005 Sep 25; 45(8):1012-22. PubMed ID: 16109115
    [Abstract] [Full Text] [Related]

  • 11. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Sep 25; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 12. Topiramate monotherapy in epilepsy and migraine prevention.
    Silberstein SD, Ben-Menachem E, Shank RP, Wiegand F.
    Clin Ther; 2005 Feb 25; 27(2):154-65. PubMed ID: 15811478
    [Abstract] [Full Text] [Related]

  • 13. Topiramate improves health-related quality of life when used to prevent migraine.
    Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC.
    Headache; 2005 Sep 25; 45(8):1023-30. PubMed ID: 16109116
    [Abstract] [Full Text] [Related]

  • 14. Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study.
    Villani V, Ciuffoli A, Prosperini L, Sette G.
    Headache; 2011 Feb 25; 51(2):287-91. PubMed ID: 21284610
    [Abstract] [Full Text] [Related]

  • 15. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE, Abbasi V, Sajedi SA, Majdinasab N, Abdollahi F, Hajmanouchehri R, Faraji A.
    Clin Neuropharmacol; 2011 Feb 25; 34(4):174-7. PubMed ID: 21738025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul 25; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 18. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep 25; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD.
    Headache; 2017 Jan 25; 57(1):165-178. PubMed ID: 27902848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.